Live attenuated vaccine: the first clinically approved dengue vaccine? - Test2 - elhamkhani - TriplyDB

Live attenuated vaccine: the first clinically approved dengue vaccine?

Live attenuated vaccine: the first clinically approved dengue vaccine?

http://www.wikidata.org/entity/Q42998710

about

Mouse models to study dengue virus immunology and pathogenesis Therapeutic Potential of Spirooxindoles as Antiviral Agents Discovery of Dengue Virus NS4B Inhibitors.CD8+ T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice.Dengue Virus Infection of Aedes aegypti Requires a Putative Cysteine Rich Venom Protein.Socioeconomic and environmental determinants of dengue transmission in an urban setting: An ecological study in Nouméa, New Caledonia.A novel mosquito ubiquitin targets viral envelope protein for degradation and reduces virion production during dengue virus infection.Lead optimization of spiropyrazolopyridones: a new and potent class of dengue virus inhibitors.Refolding of a fully functional flavivirus methyltransferase revealed that S-adenosyl methionine but not S-adenosyl homocysteine is copurified with flavivirus methyltransferase.

P2860

Q27010151-214BCCB0-1398-4049-84F2-9E670F0676E7 Q33637160-6ACB70D9-E5DF-4AFD-836C-A9C783040E23 Q35643850-18F293D8-8F08-4782-A55B-D18DDCE0823F Q35760439-5C7616DB-7372-40D2-B04C-A4351EDF5021 Q35817119-EC2CAECC-BF29-4C17-8606-9DBCAF61E524 Q36332097-B609A327-FA5E-49C0-8B07-B31C92D44C78 Q38860632-3C598DD0-4877-4442-B1EF-6E76EFD992F5 Q39633694-F378469B-37D1-4C8F-BC06-71C5AE9B07FE Q40185164-C71D72DF-B1BB-4B9C-8DD1-9AF41D0B1859

P2860

Live attenuated vaccine: the first clinically approved dengue vaccine?

http://www.wikidata.org/entity/Q42998710

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Live attenuated vaccine: the first clinically approved dengue vaccine?

@en

Live attenuated vaccine: the first clinically approved dengue vaccine?

@nl

type

label

Live attenuated vaccine: the first clinically approved dengue vaccine?

@en

Live attenuated vaccine: the first clinically approved dengue vaccine?

@nl

prefLabel

Live attenuated vaccine: the first clinically approved dengue vaccine?

@en

Live attenuated vaccine: the first clinically approved dengue vaccine?

@nl

P1433

Q42998710-34C56E5F-3022-4D07-AF7E-257145919821

P1476

Q42998710-07C760AC-96EE-4F50-A534-A2613F6F8B56

P2093

Q42998710-DCAA65CC-B10E-417B-989C-9CA7D8FFB68F

P2860

Q42998710-05111B8A-78D3-4FCC-8476-E656C0C6B3E6

Q42998710-07399CFC-9F30-4A6D-BF6F-7E831191E36C

Q42998710-2249F798-527F-40D8-A17C-8F3EF45E510C

Q42998710-426A389B-006F-4799-9669-EA3AAB1DF557

Q42998710-4F2CEFAD-623E-4CAA-BC67-D7DE40DE24BF

Q42998710-4F6B0957-79BC-4E0F-BD53-D06FD1DBF283

Q42998710-616CACD8-7DB5-4A3A-BB3C-583BBA6951DB

Q42998710-66D9B177-7788-4497-A053-DD6BAC297276

Q42998710-86B3FE30-C6E7-41CD-A07B-7FAC9B23F909

Q42998710-9B58A315-7747-4500-8E21-5DD8BC9B76A2

P304

Q42998710-51172AFB-51C1-477C-BFF6-958F7066C8A0

P31

Q42998710-07c55a8f-8014-48c6-bc18-cc39f317b75c

Q42998710-77416B44-F55C-4D3A-8BB8-1C1493712DE9

P356

Q42998710-417BD145-7EC5-4210-8DD5-A5CAB7E66A19

P433

Q42998710-9DD4FB17-C351-4D71-BD84-600603E781D0

P478

Q42998710-CF30DAF7-104E-4110-A3D1-85BE52829F8C

P50

Q42998710-3FDED99E-D04E-44E5-ACDF-E2C6ABC2397B

P577

Q42998710-A6698F5E-E3C6-4694-BAE8-6DC18390353A

P5875

Q42998710-191AC6DC-F76E-4E58-8E3D-9D7ACBF56040

P698

Q42998710-9C5CD89D-4BCD-49A4-8D65-AD71204AD318

P921

Q42998710-69D863AE-1D7A-41A3-ACA9-1CDF8AA12F0A

Q42998710-D82141E1-B0E5-446A-AEE4-9F000D33DEBA

P356

14760584.2014.870888

P1433

Expert Review of Vaccines

P1476

Live attenuated vaccine: the first clinically approved dengue vaccine?

@en

P2093

Katja Fink

http://www.w3.org/2001/XMLSchema#string

P2860

Rational design of a live attenuated dengue vaccine: 2'-o-methyltransferase mutants are highly attenuated and immunogenic in mice and macaques

Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II

A Protective Role for Dengue Virus-Specific CD8+ T Cells

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

Determinants of inapparent and symptomatic dengue infection in a prospective study of primary school children in Kamphaeng Phet, Thailand

Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever.

CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination.

Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection.

Genetic and phenotypic characterization of manufacturing seeds for a tetravalent dengue vaccine (DENVax).

Heterotypic dengue infection with live attenuated monotypic dengue virus vaccines: implications for vaccination of populations in areas where dengue is endemic.

P304

185-188

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14760584.2014.870888

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259385456

http://www.w3.org/2001/XMLSchema#string

P698

24350687

http://www.w3.org/2001/XMLSchema#string

P921

attenuated vaccine